Charles River Laboratories International (CRL) Competitors $154.36 -3.68 (-2.33%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$153.32 -1.04 (-0.67%) As of 07/15/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, MTD, WAT, ILMN, BIO, BRKR, PACB, and HBIOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Icon (ICLR), Bio-Techne (TECH), IQVIA (IQV), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), and Harvard Bioscience (HBIO). Charles River Laboratories International vs. Its Competitors Icon Bio-Techne IQVIA Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation. Which has stronger earnings and valuation, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.42$791.47M$9.1815.86Charles River Laboratories International$4.05B1.87$22.20M-$0.65-237.48 Is ICLR or CRL more profitable? Icon has a net margin of 9.25% compared to Charles River Laboratories International's net margin of -0.66%. Charles River Laboratories International's return on equity of 15.19% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.25% 11.46% 6.49% Charles River Laboratories International -0.66%15.19%6.93% Which has more risk and volatility, ICLR or CRL? Icon has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500. Do analysts prefer ICLR or CRL? Icon currently has a consensus price target of $198.08, indicating a potential upside of 36.06%. Charles River Laboratories International has a consensus price target of $174.54, indicating a potential upside of 13.07%. Given Icon's stronger consensus rating and higher possible upside, equities research analysts clearly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.60Charles River Laboratories International 1 Sell rating(s) 10 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.25 Does the media favor ICLR or CRL? In the previous week, Charles River Laboratories International had 1 more articles in the media than Icon. MarketBeat recorded 13 mentions for Charles River Laboratories International and 12 mentions for Icon. Charles River Laboratories International's average media sentiment score of 1.15 beat Icon's score of 0.88 indicating that Charles River Laboratories International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in ICLR or CRL? 95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryIcon beats Charles River Laboratories International on 10 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$7.76B$7.25B$5.61B$20.82BDividend YieldN/A2.86%4.23%3.65%P/E Ratio-237.4834.4428.5427.17Price / Sales1.8734.49429.2447.97Price / Cash7.2825.1136.0222.28Price / Book2.288.098.144.56Net Income$22.20M$236.06M$3.24B$995.22M7 Day Performance-2.78%-3.35%0.18%-1.16%1 Month Performance2.11%-0.38%5.96%3.18%1 Year Performance-32.13%19.35%26.24%6.83% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.8137 of 5 stars$154.36-2.3%$174.54+13.1%-28.6%$7.76B$4.05B-237.4820,100Positive NewsICLRIcon4.4414 of 5 stars$147.59-1.7%$213.08+44.4%-57.3%$11.92B$8.19B16.0841,900Upcoming EarningsTECHBio-Techne4.8686 of 5 stars$51.53-3.0%$72.00+39.7%-33.4%$8.08B$1.16B62.843,100News CoverageIQVIQVIA4.9197 of 5 stars$162.57-1.0%$226.32+39.2%-30.2%$28.12B$15.41B22.1588,000Upcoming EarningsMTDMettler-Toledo International3.9731 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-14.2%$24.69B$3.87B29.6317,300Positive NewsWATWaters4.8754 of 5 stars$346.35-1.1%$388.00+12.0%-4.3%$20.61B$2.96B31.437,600Trending NewsAnalyst ForecastILMNIllumina4.8388 of 5 stars$97.15-3.6%$127.39+31.1%-16.7%$15.38B$4.37B-16.009,030Positive NewsBIOBio-Rad Laboratories4.6788 of 5 stars$247.45-1.6%$324.25+31.0%-18.1%$6.73B$2.57B-3.257,700News CoverageAnalyst DowngradeAnalyst RevisionBRKRBruker4.9782 of 5 stars$41.27-2.8%$52.89+28.2%-33.8%$6.25B$3.37B79.3711,396Positive NewsHigh Trading VolumePACBPacific Biosciences of California1.8313 of 5 stars$1.47-8.1%$2.06+40.2%-11.1%$441.13M$152.36M-0.53730Gap DownHBIOHarvard Bioscience4.2307 of 5 stars$0.44-2.2%$3.00+577.2%-88.0%$19.59M$94.14M-0.34490 Related Companies and Tools Related Companies Icon Alternatives Bio-Techne Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
